Skip to main content
. 2019 Oct 22;2019(10):CD013459. doi: 10.1002/14651858.CD013459
Study ID First author Year of publication Journal of publication
Setting Country Plague prevalence and endemicity in study setting Study start and end dates
Study design Whether patients were enrolled prospectively or retrospectively Sampling strategy (consecutive or random) Inclusion and exclusion criteria
Target condition Any form of plague or a particular form of plague (bubonic, septicaemic, pneumonic), with case definitions
Participants Sample size Characteristics: age, gender, comorbidities Signs and symptoms presented Recent prior antibiotic treatment
Index test Brand name, target antigen, batch numbers Which biological sample was tested (urine, sputum, bubo aspirate)? Transport and storage condition Need for sample preparation Who performed the test (including any special training provided)? Where was the test performed (field or laboratory)? Threshold considered for positive result?
Reference standard Which reference standard was used (culture, PCR, serology, combination)? Which biological sample was tested (blood, urine, sputum, bubo aspirate)? Who performed the reference standard test(s) (including training level)? Where was the test performed? How many observers or repeats were used? Time between RDT and reference test? Blinding of operator to RDT result? Has the laboratory received quality accreditation by an external agency?
Index and reference standard test results Numbers of true positives, false positives, true negatives and false negatives Number of uninterpretable or doubtful results
Notes Source of funding Anything else of relevance